[Federal Register Volume 66, Number 242 (Monday, December 17, 2001)]
[Notices]
[Pages 64981-64982]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-30950]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-18]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 639-7090. CDC is requesting an emergency 
clearance for this data collection and that OMB act on this package 3 
weeks after the publication of this Federal Register Notice.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 14 days 
of this notice.
    Proposed Project: Program Evaluation of the Distribution of 
Antimicrobial Agents to Prevent Anthrax, Assessment of Adverse Events 
and Adherence--New--National Center for Infectious Disease (NCID), 
Centers for Disease Control and Prevention. A 60-day course of 
antimicrobial prophylaxis has been recommended for approximately 7,500 
persons with exposures to Bacillus anthracis related to bioterrorist 
attacks. To provide the antimicrobial agents necessary to meet this 
need, the National Pharmaceutical Stockpile (NPS) and the Centers for 
Disease Control and Prevention (CDC) has continued to support state and 
local health departments in responding to a nationwide public health 
emergency. This support has consisted of both the provision of 
additional antimicrobial agents as well as technical assistance from 
CDC to ensure effective transfer and distribution of supplies and 
medications, assess ongoing needs, and assist in management of other 
issues arising from the distribution of stockpile materials.
    In order to evaluate this program, a telephone interview will be 
administered to persons who were recommended to receive 60 days of 
antibiotics after potential exposure to anthrax. The purpose of this 
interview will be to assess the provision of stockpile medications at 
60 days after initiation of prophylactic campaigns for inhalation 
anthrax, assess the number of antibiotic-related adverse events, and 
determine the adherence to antimicrobial regimens. Results of this 
evaluation will be an important tool to determine the level and 
characteristics of technical assistance that the NPS and CDC will need 
to provide with any future anthrax post-exposure prophylaxis campaigns. 
This systematic approach to evaluation of an essential organization 
practice in public health will be used to improve public health 
actions. There is no cost to the respondent.

[[Page 64982]]



----------------------------------------------------------------------------------------------------------------
                                                                                          Average
                                                               Number of    Number of    burden per     Total
                         Respondents                          respondents   responses/    response   burden  (in
                                                                            respondent   (in hours)     hours)
----------------------------------------------------------------------------------------------------------------
Telephone interview.........................................        7,500            1         5/60          625
                                                                                                    ------------
    Total...................................................  ...........  ...........  ...........          625
----------------------------------------------------------------------------------------------------------------


    Dated: December 10, 2001.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control, and Prevention.
[FR Doc. 01-30950 Filed 12-14-01; 8:45 am]
BILLING CODE 4163-18-P